Terns Pharmaceuticals, Inc.·4

Feb 3, 6:00 PM ET

Quirk Erin 4

4 · Terns Pharmaceuticals, Inc. · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
Quirk Erin
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-01+600,000600,000 total
    Exercise: $8.94Exp: 2033-01-31Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT